VaxigripTetra, suspenzija za injekciju u napunjenoj štrcaljki, četverovalentno cjepivo protiv influence (fragmentirani virion, inaktivirano)
| Name | VaxigripTetra, suspenzija za injekciju u napunjenoj štrcaljki, četverovalentno cjepivo protiv influence (fragmentirani virion, inaktivirano) |
|---|---|
| Marketing Authorisation Number | HR-H-888872987 |
| Active Substance | Soj virusa influence (inaktivirani, fragmentirani) Tip A (H1N1) Soj virusa influence (inaktivirani, fragmentirani) Tip A (H3N2) Soj virusa influence (inaktivirani, fragmentirani) Tip B |
| Composition | jedna doza (0,5 ml) sadrži 15 mikrograma hemaglutinina po soju virusa influence (inaktivirani, fragmentirani) za sezonu aktualnih sojeva, tip A (H1N1), tip A (H3N2) i dva soja tipa B |
| Pharmaceutical Form | suspenzija za injekciju u napunjenoj štrcaljki |
| Manufacturer | Sanofi-Aventis Zrt., Budimpešta, Mađarska
Sanofi Winthrop Industrie, Val de Reuil, Francuska Sanofi Winthrop Industrie, Marcy L Etoile , Francuska |
| Marketing Authorisation Holder | Sanofi Winthrop Industrie, 82, avenue Raspail, Gentilly, Francuska |
| Marketing Authorisation Date | 24.12.2024 |
| MA Period of Validity | unlimited |
| Classification Number | UP/I-530-09/20-02/123 |
| Registration Number | 381-12-01/171-24-46 |
| Prescription | Medicinal product subject to medical prescription |
| Type of prescription | neponovljivi recept |
| Distribution | Supply through pharmacies (community) |
| Advertising to general public | not allowed |
| ATC Code | J07BB02 |
| Marketing status | trajni prekid opskrbe |
| SmPC | download |
| PL | download |
| Public Assessment Report | download |
